Tin t&#x1EE9;c &amp; C&#x1EAD;p nh&#x1EAD;t

Patient-related factors, such as sex, comorbidities, and medical history, affect the risk of early mortality in drug-resistant tuberculosis (DR-TB), reports a recent meta-analysis.

Which factors increase risk of death in drug-resistant TB?

A third of symptomatic COVID-19 patients have persistent symptoms

Around a third of symptomatic patients with the novel coronavirus disease (COVID-19) seem to develop persistent symptoms, a recent study has found. On the other hand, a third of all patients with polymerase chain reaction-confirmed COVID-19 are asymptomatic, underscoring the heterogeneity of its presentation.

A third of symptomatic COVID-19 patients have persistent symptoms

Ivermectin not effective against COVID-19

02 Jul 2021 bởi

Treatment with ivermectin does not reduce all-cause mortality, length of stay (LOS), or respiratory viral clearance in randomized controlled trials (RCTs) of patients with mild to moderate COVID-19 when compared with placebo or standard of care (SOC), results of a systematic review and meta-analysis have shown. In addition, it has failed to moderate adverse events (AEs) or severe AEs.

Ivermectin not effective against COVID-19

02 Jul 2021

No increased SSI risk with dexamethasone

A single dose of dexamethasone during nonurgent, noncardiac surgery does not increase the risk of surgical-site infection (SSI), according to results of the PADDI* trial.

No increased SSI risk with dexamethasone

Original New Drug Application Approvals by US FDA (16 - 30 June 2021)

New drug applications approved by US FDA as of 16-30 June 2021 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (16 - 30 June 2021)

Race is most important predictor of SARS-CoV-2 infection, says study

Race or ethnicity strongly predicts the risk of infection with SARS-CoV-2, the causative agent of COVID-19, according to a recent study. Following infection, race correlates with an increased hospitalization risk but not mortality.

Race is most important predictor of SARS-CoV-2 infection, says study

SG’s Circuit Breaker, DORSCON Orange discourage people to seek care for other infections

Singapore’s nonpharmaceutical interventions (NPIs) and public education campaigns to combat the novel coronavirus have also led to a drop in primary care attendances for other acute respiratory infections (ARIs), according to a recent study.

SG’s Circuit Breaker, DORSCON Orange discourage people to seek care for other infections

Antigen rapid tests: Moving toward more efficient COVID-19 testing

At the time of writing, there have been 175,306,598 confirmed infections and 3,792,777 deaths attributed to the COVID-19 pandemic globally. [https://covid19.who.int/, accessed 14 June 2021] Real-time reverse transcription polymerase chain reaction (RT-PCR) has been instrumental in detecting the infection and preventing more widespread transmission of the disease.

Antigen rapid tests: Moving toward more efficient COVID-19 testing